ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronEye IconIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailMenu BurgerPositive ArrowIcon PrintIcon SearchSite TitleTitle ChevronIcon Twitter
Process Industries

Ube Industries Ltd.

Business Summary

Ube Industries Ltd. engages in the chemical, pharmaceutical, construction material, machinery and metal, and energy and environment businesses. It operates through the following business segments: Chemicals, Pharmaceuticals, Cement and Construction Materials, Machinery, Energy and Environment, and Others. The Chemicals segment offers caprolactam, industrial chemicals, synthetic rubbers, battery materials, fine chemicals, and polyimide. The Pharmaceuticals segment deals with the manufacture and sale of proprietary drugs, active pharmaceutical ingredients, and intermediates. The Cement and Construction Materials segment includes cement, ready-mix concrete, limestone, calcium magnesia, building materials, functional inorganic materials, and resource recycling. The Machinery segment manages the manufacture and sale of molding machinery, industrial machinery, bridge and iron structure, and steel products. The Energy and Environment segment handles the sale and import of coal, call center operation, and wholesale power supply business (IPP). The Others segment consists of the development, sale, and brokerage of real estate properties as well as the sale of products overseas. The company was founded by Sukesaku Watanabe in June 1897 and is headquartered in Ube, Japan.

Financial Highlights

Mar 2019 JPYUSD
Revenue730,157M6,584.23M
Gross Profit130,173M1,173.84M
Operating income44,551M401.74M
Income before tax44,678M402.88M
Net income32,499M293.06M
EBITDA81,118M731.48M
Diluted EPS311.352.80
Dividends Per Share800.72
Total Assets740,286M6,688.22M
Total liabilities385,734M3,484.97M
Total equity330,146M2,982.75M
Operating cash flow50,462M455.04M
Currency in JPYCurrency in USD

Historical Data

 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 641,759M 641,750M 616,563M 695,574M 730,157M
Gross Profit 102,720M 121,709M 115,901M 135,664M 130,173M
Operating income 23,999M 41,261M 34,818M 50,250M 44,551M
Income before tax 18,491M 27,653M 32,933M 45,000M 44,678M
Net income 14,649M 19,111M 24,185M 31,680M 32,499M
EBITDA 57,733M 76,982M 69,450M 85,749M 81,118M
Diluted EPS 138.10 180.10 227.80 300.63 311.35
Dividends Per Share 50 50 60 75 80
Total Assets 711,546M 679,783M 709,379M 742,445M 740,286M
Total liabilities 420,951M 389,203M 398,978M 405,584M 385,734M
Total equity 263,892M 267,159M 287,222M 316,024M 330,146M
Operating cash flow 62,194M 68,628M 53,418M 73,386M 50,462M
 Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Revenue 5,841.79M 5,344.16M 5,693.75M 6,275.90M 6,584.23M
Gross Profit 935.03M 1,013.52M 1,070.30M 1,224.04M 1,173.84M
Operating income 218.45M 343.60M 321.53M 453.38M 401.74M
Income before tax 168.31M 230.27M 304.12M 406.01M 402.88M
Net income 133.34M 159.14M 223.34M 285.83M 293.06M
EBITDA 525.53M 641.06M 641.34M 773.68M 731.48M
Diluted EPS 1.25 1.49 2.10 2.71 2.80
Dividends Per Share 0.45 0.41 0.55 0.67 0.72
Total Assets 5,933.25M 6,048.16M 6,366.14M 6,981.14M 6,688.22M
Total liabilities 3,510.11M 3,462.81M 3,580.52M 3,813.67M 3,484.97M
Total equity 2,200.47M 2,376.96M 2,577.60M 2,971.54M 2,982.75M
Operating cash flow 566.13M 571.49M 493.29M 662.13M 455.04M

Valuation Measures

Mar 2019
PER7.28
ROA4.38%
ROE10.05%
Operating margin6.10%
Profit margin4.45%

Key executives

  • President & Representative Director: Masato Izumihara
  • Group CFO & Manager-Business Administration: Masayuki Fujii
  • Executive Officer, GM-Research & Development: Morihisa Yokota
  • Chief Compliance Officer & Manager-Personnel: Hideo Tamada
  • Executive Officer: Makoto Aikawa

Shareholders

  • Ube Industries Ltd. (4.8%)
  • Nomura Asset Management Co., Ltd. (4.6%)
  • Asset Management One Co., Ltd. (3.7%)
  • BlackRock Fund Advisors (3.3%)
  • Sumitomo Mitsui Trust Asset Management Co., Ltd. (2.9%)
  • The Vanguard Group, Inc. (2.4%)
  • Nikko Asset Management Co., Ltd. (1.9%)
  • Sumitomo Life Insurance Co. (1.8%)
  • Dimensional Fund Advisors LP (1.8%)
  • Norges Bank Investment Management (1.6%)

Contact Details

Related Companies

  • UBE Exsymo Co., Ltd.
  • Lotte Ube Synthetic Rubber Sdn. Bhd.
  • Ube Industries Central Hospital Corp.
  • UBE Industries India Pvt Ltd.
  • UBE (Thailand) Co. Ltd.
  • UBE-Nitto Kasei (Wuxi) Co. Ltd.
  • UBE Machinery Thai Co. Ltd.
  • UBE Korea Co. Ltd.
  • Advanced Electrolyte Technologies LLC
  • Ube Industries Pension Fund
  • Ubon Bio Ethanol PCL
  • Ube Asset & Insurance Ltd.
  • Ana Hotel Ube Ltd.
  • Ube Realty & Development Co. Ltd.
  • Libertas Ube Ltd.
  • UBE (Shanghai) Ltd.
  • UBE (Hong Kong) Ltd.
  • UBE Singapore Pte Ltd.
  • Ube Industries Consulting Ltd.
  • Yamayo Trading Co. Ltd.
  • Ube Aluminum Wheels Ltd.
  • Fukusei Tech Co. Ltd.
  • Fukusei Vender Service Co. Ltd.
  • Nantong Ube Concrete Co. Ltd.
  • Kitakyushu Ube Concrete Co. Ltd.
  • Kano Ube Concrete Co. Ltd.
  • Nishiharima Ube Co. Ltd.
  • Kansai Ube Co. Ltd.
  • Chiba Ube Concrete Co. Ltd.
  • Ozawa Corp.

Competitors

  • BASF SE
  • Arkema SA
  • AdvanSix, Inc.
  • Shenzhen Capchem Technology Co., Ltd. Class A
  • Guangdong Yizumi Precision Machinery Co. Ltd. Class A
  • Kaset Thai International Sugar Corp. Public Co. Ltd.
  • CytoSorbents Corporation
  • Syros Pharmaceuticals, Inc.
  • Thai Agro Energy Public Co., Ltd.
Last Updated on 21 Oct, 2019

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this monthThis is your last free article this month

Stay ahead with our exclusives on Asia;
the most dynamic market in the world.

Stay ahead with our exclusives on Asia

Get trusted insights from experts within Asia itself.

Get trusted insights from experts
within Asia itself.

Get Unlimited access

You have {{numberArticlesLeft}} free article{{numberArticlesLeft-plural}} left this month

This is your last free article this month

Stay ahead with our exclusives on Asia; the most
dynamic market in the world
.

Get trusted insights from experts
within Asia itself.

Try 3 months for $9

Offer ends October 31st

Your trial period has expired

You need a subscription to...

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers and subscribe

Your full access to the Nikkei Asian Review has expired

You need a subscription to:

  • Read all stories with unlimited access
  • Use our mobile and tablet apps
See all offers
NAR on print phone, device, and tablet media